tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
KPTI
Karyopharm Therapeutics
RESEARCH TOOLSreports
Want to see KPTI full AI Analyst Report?

Karyopharm Therapeutics (KPTI) Revenue

1,235 Followers
StatisticsMarket CapRevenue

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 35.07M in the quarter ending Mar 31, 2026, with 2.90%. This bring the company's revenue in the last twelve months to 151.12M, Decreased 3.46%. In the fiscal year ending Dec 31, 2025, Karyopharm Therapeutics had annual revenue of 146.07M with 0.57% growth.
Revenue (ttm)
151.12M
Revenue Growth
6.33%
P/S Ratio
1.27
Revenue/Employee
$523,538
Employees
279
Market Cap
$184.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
146.07M830.00K+0.57%
Dec 31, 2024
145.24M-796.00K-0.55%
Dec 31, 2023
146.03M-11.04M-7.03%
Dec 31, 2022
157.07M-52.74M-25.14%
Dec 31, 2021
209.82M101.73M+94.12%
Dec 31, 2020
108.08M67.19M+164.31%
Dec 31, 2019
40.89M10.56M+34.80%
Dec 31, 2018
30.34M28.73M+1,790.09%
Dec 31, 2017
1.60M――